Health and Nutrition

Advancing Research in Voice Disorders (R21)

This funding opportunity announcement (FOA) seeks Research Project Grant (R21) applications that are focused on advancing our scientific knowledge of the Human Larynx and Human Voice Production in Health and Disease and optimal ways to prevent, evaluate, diagnose and clinically manage voice disorders.

Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03)

This funding opportunity announcement (FOA) encourages a wide range of collaborative research projects related to patient safety in the context of perinatal, neonatal and pediatric care both in routine hospital settings and in the intensive care units. The FOA welcomes applications related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional levels to help reduce and eliminate medical errors.

Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01)

This funding opportunity announcement (FOA) encourages a wide range of collaborative research projects related to patient safety in the context of perinatal, neonatal and pediatric care both in routine hospital settings and in the intensive care units. The FOA welcomes applications related to (but not limited to): the epidemiology of various domains of medical errors and consequent patient harm; assessing the factors at various levels that contribute to such errors; and intervention strategies at individual, systems, and institutional levels to help reduce and eliminate medical errors.

Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R41/R42)

This funding opportunity announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose development of a broad base of innovative technologies in biomedical computing, informatics, and Big Data Science that will support rapid progress in areas of scientific opportunity in biomedical research. It is expected that this research and development is conducted in the context of important biomedical and behavioral research problems.

Extended Development, Hardening and Dissemination of Technologies in Biomedical Computing, Informatics and Big Data Science (R01)

The goal of this program announcement is to support the extended development, maintenance, testing, evaluation, hardening and dissemination of existing biomedical software. The NIH is interested in promoting a broad base of research and development of technologies in biomedical computing, informatics, and Big Data Science that will support rapid progress in areas of scientific opportunity in biomedical research.

Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01)

The NIH is interested in promoting a broad base of research and development of technologies in biomedical computing, informatics, and Big Data Science that will support rapid progress in areas of scientific opportunity in biomedical research. It is expected that this research and development is conducted in the context of important biomedical and behavioral research problems.

Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R43/R44)

This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose development of a broad base of innovative technologies in biomedical computing, informatics, and Big Data Science that will support rapid progress in areas of scientific opportunity in biomedical research. It is expected that this research and development is conducted in the context of important biomedical and behavioral research problems.

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01)

The purpose of this funding opportunity announcement (FOA) is to (1) promote preclinical, translational, clinical and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments.

Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01)

This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.Applications should propose well-integrated studies using either single or mixed methods.Proposed methods may include, but are not limited to, data-generating qualitative or quantitative approaches, legal, economic or normative analyses, or other analytical or conceptual research methodologies.

Innovative Therapies and Tools for Screenable Disorders in Newborns (R03)

This Funding Opportunity Announcement (FOA encourages Research Project Grant (R03) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future.In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.